Nov 2
Earnings call
Q2 2027 earnings call
IOL Chemicals and Pharmaceuticals Ltd. reported Q2 FY27 revenue of Rs.795 CR, up approximately 40% Y1Y, and a 14.4 percentage EBITDA margin. Management guided FY27 revenue growth to around 25% plus and EBITDA margin to 14-15%.